Home LiteratureArticle Details
PMID: 14965245 Published · ppublish English Journal Article Review

5-ht6 receptors.

Current drug targets. CNS and neurological disorders ·Vol. 3 ·No. 1 ·2004-02-00 ·Pages 59-79

Woolley ML, Marsden CA, Fone KC

Abstract

The 5-hydroxytryptamine(6) (5-ht(6)) was one of the most recent additions to the 5-HT receptor family, selective antagonists have recently been developed and potential functional roles are now becoming apparent. The high affinity of a wide range of psychiatric drugs for the 5-ht(6)receptor, together with its almost exclusive expression in the CNS, being abundant in limbic and cortical regions, has stimulated significant research interest. The 5-ht(6)receptor appears to regulate glutamatergic and cholinergic neuronal activity, and increasing evidence suggests that it may be involved in the regulation of cognition, feeding and, possibly, affective state and seizures. The current article will review all aspects of the discovery, genetics, distribution, pharmacology and function of the 5-ht(6)receptor. Taken together, this wealth of information warrants the use of the upper case nomenclature for the 5-ht(6) receptor to be approved and its true status recognised.

MeSH Terms
Animals Brain/drug effects,metabolism Cloning, Molecular Drug Evaluation/methods Feeding Behavior/drug effects,physiology Humans Learning/drug effects,physiology Mental Disorders/drug therapy,physiopathology Mice Neurons/drug effects,metabolism Polymorphism, Genetic Rats Receptors, Serotonin/classification,drug effects,genetics,metabolism Serotonin Antagonists/pharmacology Serotonin Receptor Agonists/pharmacology Signal Transduction Structure-Activity Relationship Tissue Distribution
Chemicals
Receptors, Serotonin Serotonin Antagonists Serotonin Receptor Agonists serotonin 6 receptor
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Woolley Marie L
Institute of Neuroscience, School of Biomedical Science, Queen's Medical Centre, University of Nottingham, Nottingham, NG7 2UH, UK.
Marsden Charles A
Fone Kevin C F
Article Info
Journal
Current drug targets. CNS and neurological disorders
Abbr.
Curr Drug Targets CNS Neurol Disord
ISSN
1568-007X
Published
2004-02-00
Pages
59-79
Language
English
Region
Netherlands
NLM ID
101151150
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com